 Michael Pearson runs a drug company, but that doesn't mean he wants to spend money on science. . By contrast, science is prized at the company he wants to buy, Allergan Inc. The Botox maker spends 17% of its revenue on research and development, higher than many of its rivals. . That culture clash and Mr. Pearson's reputation as an aggressive...
  